Life with BCC


The most important thing for people with cancer is receiving effective treatment. But managing cancer involves much more than effective treatment. Any cancer diagnosis comes with physical and emotional challenges and profound life changes. At first, it may be difficult to realize exactly how big a change cancer may bring. As a result, people diagnosed with cancer may have difficulty adjusting.

Negative Impact of Advanced BCC Patients

  • 57% of patients had limited activities, such as exercise, strenuous activities, such as lifting heavy objects, or outdoor activities, to avoid sun exposure. [1,2]
  • Approximately 50% of patients described their disease as visible (with scarring). [1,2]
  • Approximately 50% of patients reported experiencing self-consciousness or feeling embarrassed about their appearance due to scarring. [1,2]
  • 52% of patients reported an impact on their social or leisure activities. [1,2]
  • 19% of patients experienced fatigue, limiting their ability to complete every-day activities.[1,2]

More than half of patients with advanced BCC report a negative impact of disease on their emotional functioning [1,2]

  • 43% feel anxious
  • 36% feel depressed or use antidepressans
  • 29% feel unable to focus or difficulty concentrating
  • 29% feel worry regarding future surgical and other procedures


A cancer diagnosis can be overwhelming. But you don’t have to face the challenges alone. The Melanoma Network of Canada offers a wide variety of free services to support patients, families and caregivers through every step of their journey.

Phone & Email Support

Available Monday to Friday, 9am – 5pm EST. We aim to respond to all inquiries within 48 hours.
For support call:
Mary Zawadzki – Patient Care Specialist B.A, SSW, RSSW
905.901.5121 x108 or 1.877.560.8035 x108
or email

Live Chat

Click on the Chat Icon on the bottom right hand corner and connect with Mary Zawadzki – Patient Care Specialist B.A, SSW, RSSW

BCC Online Patient Forum

Melanoma Network of Canada online discussion forum provides a place to ask questions or provide insights and information on your own experience with other patients and caregivers. It is a great way to get a timely response to your questions or concerns. Visit our Discussion Forum

Why Get Support?

Using our support services may help you:

  • Feel more connected to others who understand living with BCC
  • Gain a sense of empowerment and control
  • Improve coping skills and adjustment to a cancer diagnosis
  • Talk openly and honestly about your feelings
  • Reduce distress, depression or anxiety
  • Get a clearer understanding of what to expect
  • Learn about new medical research
  • Get practical information about treatment options
  • Compare notes about resources, such as doctors and alternative options

We are here to listen and support you anywhere in Canada – you are not alone! 

About Melanoma Network of Canada Support Services

Please note we do not give medical advice, but can assist people with melanoma and other forms of skin cancer by answering questions, reviewing their diagnosis and treatment options, clinical trial information and helping to make sense of often complex terminology and information. If we can’t answer your questions, MNC will research your specific question or request and provide you with a timely response wherever possible, either by phone or email. We try to help you navigate your diagnosis and the medical system wherever possible. For most of us, the diagnosis alone, can be stressful enough. We are here to help support and direct you to the right information and resources.

BCC Patient Forum

A place to ask questions or provide insights and information on your own experience with other patients and caregivers.

Basal Cell Carcinoma (BCC) Treatments

Treatment options for BCC patients.

Types of Basal Cell Carcinoma (BCC)  

Learn about the several distinct clinical types of BCC


1.Sanofi Advnaced Basal Cell Carcinoma Burdon of Illness

2.Steenrod, Anna W, et al. Dermatology and therapy5.3 (2015): 183-199; 2. Aymonier M, et al. Journal of the American Academy of Dermatology81.4 (2019